Indian generic drugmakers such as Sun Pharma, Cipla, Dr Reddy's and Lupin are beginning to develop their own versions of Novo Nordisk's blockbuster weight-loss drug Wegovy. Some analysts predict the weight-loss drug market could reach $100 billion annually by 2030 as obesity rates rise globally. Novo Nordisk has been unable...
India’s Sun Pharma to Distribute Bayer’s Renal Drug
India's Sun Pharmaceutical Industries Limited and Bayer have signed an agreement allowing Sun Pharma to market and distribute a second brand of the drug finerenone in India under the brand name Lyvelsa. Finerenone is a patented medicine indicated to reduce the risk of sustained decline in kidney function, end-stage kidney...
Novartis’ Cardiac Drug to Go Off-Patent in January
Swiss-American multinational pharmaceutical, Novartis AG's drug Vymada or Entresto used for patients with heart failure becomes off-patent in January, 2023 Heart failure is a progressive chronic syndrome characterized by a decrease in the functions of the heart and quality of life. 23 million people are affected by it worldwide, while...
Sun Pharma Plans to Sell Drug for Neonatal Seizures in USA
Mumbai-based Sun Pharma, signed a licensing agreement with Sun Pharma Advanced Research Company (SPARC) to commercialize the drug benzyl alcohol and propylene glycol-free phenobarbital sodium powder, SEZABY for the treatment of neonatal seizures, in the U.S. market. SPARC submitted a new drug application to the U.S. Food and Drug Administration...
Merck Licenses New Covid Treatment to 5 Indian Companies
Merck has inked pacts with multiple Indian companies: Cipla, Dr Reddy's Laboratories, Sun Pharma, Hetero Labs, and Emcure Pharmaceuticals to license and produce a forthcoming treatment for Covid-19. The company, formally known as MSD, is in the process of developing molnupiravir in collaboration with Ridgeback Biotherapeutics. The investigational oral antiviral...
India's Pharma Industry Becoming Increasingly Digital
The Economic Times reports that in a survey of drug making companies in India's $17 billion pharmaceutical industry the top 20 of them are changing their conservative ways of marketing for newer technology ranging from scientific detailing to doctors to using newer algorithms for better insights into issues like patient...